2014 - 2015 Seminar Series

Fall 2014

Wednesday, September 10, 2014: 

Dr. Alejandro Balazs, HMS, MGH, Ragon Institute

"Engineering Immunity Against Infectious Disease"

Wednesday, September 17, 2014: 

Dr. Jon Kagan, HMS, Children’s Hospital

“Initiation and Regulation of Antiviral Innate Immunity”

Wednesday, September 24, 2014: 

Dr. Sean Whelan, HMS

“Haploid genetic screens expose the secret lives of host factors in viral entry”

Wednesday, October 1, 2014: 

Dr. Benjamin Gewurz, HMS, BWH

“The NF-kB landscape in Epstein-Barr virus transformed B-cells”

Wednesday, October 8, 2014: 

Dr. Daniel Lingwood, HMS, MGH, Ragon Institute

“A genetic basis for effective humoral anti-viral responses”

Wednesday, October 15, 2014: 

Dr. Alan Engelman, HMS, BIDMC, DFCI

“HIV-Host Interactions for Antiviral Development”

Wednesday, October 22, 2014: 

Dr. Sir John Skehel, Medical Research Council’s (MRC) National Center for Medical Research, UK

"Sialic acid receptor recognition in influenza virus surveillance and transmission"

Wednesday, October 29, 2014: 

Dr. Priscilla Yang, HMS

“A Chemical Biology Approach to Antivirals”

Wednesday, November 5, 2014: No seminar scheduled

Wednesday, November 12, 2014: 

Dr. Elliott Kieff, Channing Laboratory, BWH

“Epstein-Barr Virus evolved super-enhancers to regulate cell cycle entry and lymphoblastoid cell growth”

Wednesday, November 19, 2014: 

Dr. Sun Hur, HMS, Children’s Hospital, Immune Disease Institute

"Innate immune mechanism for viral RNA detection: RIG-I and MDA5"

Wednesday, December 3, 2014: 

Dr. John Mekalanos, Harvard Medical School

“Viruses as modulators of bacterial pathogenesis - molecular and epidemiological aspects"

Wednesday, December 10, 2014: 

Dr. James Hogle, Harvard Medical School

“Poliovirus: a machine programmed for genome delivery”

Spring 2015

Wednesday, January 21, 2015: 

Dr. Max Nibert, Harvard Medical School

"Totiviruses and Their Use of Noncanonical Translation Strategies"

Wednesday, February 4, 2015: 

Dr. Thorsten Mempel, Center for Immunology and Inflammatory Diseases, MGH

“Cellular dynamics in lymphoid and mucosal tissues during HIV infection”

Wednesday, February 11, 2015: 

Dr. Samuel Rabkin, MGH

“Oncolytic herpes simplex viruses targeting glioblastoma stem cells and DNA damage responses”

Wednesday, February 18, 2015: 

Dr. Luk Vandenberghe, MEEI, HMS

“Viral evolution as a guide to study host-virus interaction and improve gene therapy vector design”

Wednesday, February 25, 2015: 

Dr. Michaela Gack, HMS

"RIG-I-like Receptor Regulation in Virus Infection and Immunity"

Wednesday, March 4, 2015: 

Dr. Britt Glaunsinger, U. C., Berkeley

"RNA destruction and revival during viral infection"

Wednesday, March 11, 2015: 

Dr. Pardis Sabeti, Center for Systems Biology, Harvard University

"Genomic surveillance of lassa virus, ebola virus and other global threats"

Wednesday, March 25, 2015: 

Dr. Athe Tsibris, Harvard Medical School; Division of Infectious Diseases, BWH

“Combination HIV-1 eradication therapeutics”

Wednesday, April 1, 2015: 

Dr. Harmit Singh Malik, Fred Hutchinson Cancer Research Center

“Rules of engagement: how arms races between hosts and viruses shape each other”

Wednesday, April 8, 2015: 

Dr. Michael Diamond, Washington University in St. Louis School of Medicine

"Innate Immune responses at the blood brain barrier interface regulate invasion of encephalitic viruses"

Wednesday, April 15, 2015: 

Dr. Stanley Lemon, University of North Carolina, Chapel Hill

"Tipping the balance: miR-122 and hepatitis C RNA synthesis and decay"

Wednesday, April 29, 2015: 

Dr. Daria Hazuda, Merck Research Labs

“Advances in Development of New Antiviral Agents”

Time and Location


Wednesdays, 12:30 pm


Harvard Medical School

New Research Building

Room 1031

77 Avenue Louis Pasteur

Boston, MA


Refreshments at 12:15 pm




© 2013 by the President and Fellows of Harvard College